Sfoglia per AUTORE
FELDMAN T
Collezione AO Cuneo

  

Items : 2

Phase 3 study of brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine (A+AVD) versus doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) as front-line treatment for advanced classical Hodgkin lymphoma (HL): Echelon-1 study in Journal of Clinical Oncology

2014
AO Cuneo

Ansell SM; Younes A; Connors JM; Gallamini A; Kim WS; Friedberg JW; Feldman TA; Collins G; Bartlett N; Wang J; Brady K; Sachs J; Huebner D; Hunder NNH; Radford J;

Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a interim-PET positive after two ABVD courses. in British journal of haematology / Br J Haematol. 2011 Mar;152(5):551-60. doi: 10.1111/j.1365-2141.2010.08485.x. Epub 2010 Dec 20.

2011
AO Cuneo

Gianni AM; Chauvie S; Ficola U; Fallanca F; Barrington S; Biggi A; Rambaldi A; Leone M; Mulè A; Sorasio R; Gavarotti P; Feldman T; Stelitano C; Cantonetti M; Di Raimondo F; Fiore F; Rossi A; Viviani S; Gallamini A; Patti C;